Glaukos Revenue 2014-2025 | GKOS
Glaukos annual/quarterly revenue history and growth rate from 2014 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Glaukos revenue for the quarter ending March 31, 2025 was $0.107B, a 24.58% increase year-over-year.
- Glaukos revenue for the twelve months ending March 31, 2025 was $0.405B, a 23.92% increase year-over-year.
- Glaukos annual revenue for 2024 was $0.383B, a 21.85% increase from 2023.
- Glaukos annual revenue for 2023 was $0.315B, a 11.26% increase from 2022.
- Glaukos annual revenue for 2022 was $0.283B, a 3.79% decline from 2021.
| Glaukos Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $383 |
| 2023 | $315 |
| 2022 | $283 |
| 2021 | $294 |
| 2020 | $225 |
| 2019 | $237 |
| 2018 | $181 |
| 2017 | $159 |
| 2016 | $114 |
| 2015 | $72 |
| 2014 | $46 |
| 2013 | $21 |
| Glaukos Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $107 |
| 2024-12-31 | $105 |
| 2024-09-30 | $97 |
| 2024-06-30 | $96 |
| 2024-03-31 | $86 |
| 2023-12-31 | $82 |
| 2023-09-30 | $78 |
| 2023-06-30 | $80 |
| 2023-03-31 | $74 |
| 2022-12-31 | $71 |
| 2022-09-30 | $71 |
| 2022-06-30 | $73 |
| 2022-03-31 | $68 |
| 2021-12-31 | $73 |
| 2021-09-30 | $75 |
| 2021-06-30 | $78 |
| 2021-03-31 | $68 |
| 2020-12-31 | $73 |
| 2020-09-30 | $65 |
| 2020-06-30 | $32 |
| 2020-03-31 | $55 |
| 2019-12-31 | $66 |
| 2019-09-30 | $59 |
| 2019-06-30 | $59 |
| 2019-03-31 | $54 |
| 2018-12-31 | $54 |
| 2018-09-30 | $44 |
| 2018-06-30 | $43 |
| 2018-03-31 | $40 |
| 2017-12-31 | $42 |
| 2017-09-30 | $40 |
| 2017-06-30 | $41 |
| 2017-03-31 | $36 |
| 2016-12-31 | $33 |
| 2016-09-30 | $30 |
| 2016-06-30 | $29 |
| 2016-03-31 | $23 |
| 2015-12-31 | $20 |
| 2015-09-30 | $19 |
| 2015-06-30 | $18 |
| 2015-03-31 | $15 |
| 2014-12-31 | $14 |
| 2014-09-30 | $12 |
| 2014-06-30 | $11 |
| 2014-03-31 | $8 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.703B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.550B | 80.39 |
| Thermo Fisher Scientific (TMO) | United States | $147.321B | 17.82 |
| Edwards Lifesciences (EW) | United States | $42.980B | 28.18 |
| IDEXX Laboratories (IDXX) | United States | $41.867B | 48.11 |
| Alcon (ALC) | Switzerland | $41.867B | 28.29 |
| DexCom (DXCM) | United States | $32.086B | 49.59 |
| IQVIA Holdings (IQV) | United States | $26.659B | 14.93 |
| Mettler-Toledo (MTD) | United States | $23.912B | 28.44 |
| STERIS (STE) | Ireland | $23.322B | 25.69 |
| Waters (WAT) | United States | $20.299B | 28.64 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.846B | 0.00 |
| Hologic (HOLX) | United States | $14.293B | 15.53 |
| Sysmex ADR (SSMXY) | Japan | $10.555B | 29.94 |
| Penumbra (PEN) | United States | $9.912B | 77.80 |
| Masimo (MASI) | United States | $8.638B | 31.86 |
| Globus Medical (GMED) | United States | $7.871B | 18.75 |
| Teleflex (TFX) | United States | $5.194B | 8.57 |
| TransMedics (TMDX) | United States | $4.607B | 100.15 |
| Integer Holdings (ITGR) | United States | $4.154B | 21.77 |
| PROCEPT BioRobotics (PRCT) | United States | $3.266B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.418B | 14.40 |
| Veracyte (VCYT) | United States | $2.096B | 29.41 |
| Nihon Kohden (NHNKY) | Japan | $1.988B | 22.80 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Alphatec Holdings (ATEC) | United States | $1.586B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.337B | 0.00 |
| Artivion (AORT) | United States | $1.271B | 119.08 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.944B | 5.02 |
| Beta Bionics (BBNX) | United States | $0.790B | 0.00 |
| IRadimed (IRMD) | United States | $0.737B | 37.41 |
| SiBone (SIBN) | United States | $0.731B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.561B | 8.73 |
| RxSight (RXST) | United States | $0.549B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.510B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.506B | 11.86 |
| OrthoPediatrics (KIDS) | United States | $0.495B | 0.00 |
| AxoGen (AXGN) | United States | $0.434B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.413B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.412B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.390B | 0.00 |
| NeuroPace (NPCE) | United States | $0.354B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.342B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.318B | 8.47 |
| ClearPoint Neuro (CLPT) | United States | $0.313B | 0.00 |
| 908 Devices (MASS) | United States | $0.264B | 0.00 |
| Neuronetics (STIM) | United States | $0.230B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.228B | 13.82 |
| Alpha Tau Medical (DRTS) | Israel | $0.208B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.208B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.184B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.181B | 0.00 |
| Inogen (INGN) | United States | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.152B | 0.00 |
| CVRx (CVRX) | United States | $0.148B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.135B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.133B | 0.00 |
| Accuray (ARAY) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.103B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.20 |
| EnVVeno Medical (NVNO) | United States | $0.075B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.47 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |